Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-03

Clinical Trial Update: Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether adding dexamethasone to Ramosetron improves prevention of postoperative nausea and vomiting in highly susceptib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Ramosetron (ramosetron)

Snippet

Sponsor: Yonsei University | Conditions: Nausea, Vomiting | Phase 4 | Status: COMPLETED